全文获取类型
收费全文 | 7203篇 |
免费 | 497篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 143篇 |
妇产科学 | 129篇 |
基础医学 | 908篇 |
口腔科学 | 149篇 |
临床医学 | 878篇 |
内科学 | 1618篇 |
皮肤病学 | 84篇 |
神经病学 | 789篇 |
特种医学 | 245篇 |
外国民族医学 | 2篇 |
外科学 | 1186篇 |
综合类 | 59篇 |
一般理论 | 2篇 |
预防医学 | 491篇 |
眼科学 | 65篇 |
药学 | 584篇 |
中国医学 | 12篇 |
肿瘤学 | 346篇 |
出版年
2023年 | 42篇 |
2022年 | 76篇 |
2021年 | 198篇 |
2020年 | 126篇 |
2019年 | 156篇 |
2018年 | 206篇 |
2017年 | 180篇 |
2016年 | 183篇 |
2015年 | 196篇 |
2014年 | 262篇 |
2013年 | 337篇 |
2012年 | 525篇 |
2011年 | 512篇 |
2010年 | 291篇 |
2009年 | 261篇 |
2008年 | 384篇 |
2007年 | 424篇 |
2006年 | 373篇 |
2005年 | 354篇 |
2004年 | 331篇 |
2003年 | 310篇 |
2002年 | 306篇 |
2001年 | 162篇 |
2000年 | 142篇 |
1999年 | 141篇 |
1998年 | 67篇 |
1997年 | 48篇 |
1996年 | 51篇 |
1995年 | 27篇 |
1994年 | 37篇 |
1993年 | 27篇 |
1992年 | 82篇 |
1991年 | 77篇 |
1990年 | 85篇 |
1989年 | 81篇 |
1988年 | 58篇 |
1987年 | 77篇 |
1986年 | 59篇 |
1985年 | 65篇 |
1984年 | 54篇 |
1983年 | 27篇 |
1982年 | 20篇 |
1979年 | 45篇 |
1978年 | 21篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1974年 | 23篇 |
1973年 | 21篇 |
1971年 | 20篇 |
1970年 | 18篇 |
排序方式: 共有7742条查询结果,搜索用时 15 毫秒
1.
2.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
3.
4.
5.
6.
J Prinseau A Baglin J Benoit J M Leparc C Got M F Louis B Attar D Fritel 《Annales de médecine interne》1989,140(2):94-98
The incidence of beta-2 microglobulin amyloidosis was assessed in two populations of chronic hemodialysis patients. Out of 34 patients who underwent biopsy during orthopedic surgery (33 cases) or autopsy (1 case), 26 had amyloid deposits which fixed anti-beta microglobulin serum. Out of 55 unselected patients treated for over months at the dialysis centre, 14 (25%) had clinical symptoms suggesting amyloidosis and out of 43 patients who had a systematic radiological skeletal survey, 23 (53%) had bone deposits. The plasma beta microglobulin concentrations (about 20 times the normal value) we not significantly different whether or not the patients had histological proven amyloidosis, clinically or radiologically probable amyloidosis, no detectable amyloidosis. However, the duration of hemodialysis was longer in those with proven or highly probable amyloidosis. The finding illustrate the indirect role of elevation of beta-2 microglobulin in the genesis of this pathology and also the necessity of lowering its concentration in order to avoid the long term complications of osteoarticular deposits, the functional consequences of which may be very serious. 相似文献
7.
Hillary R Bogner Mark S Cary Martha L Bruce Charles F Reynolds Benoit Mulsant Thomas Ten Have George S Alexopoulos 《The American journal of geriatric psychiatry》2005,13(10):861-868
OBJECTIVE: The authors described the influence of specific medical conditions on clinical remission and response of major depression (MDD) in a clinical trial evaluating a care-management intervention among older primary-care patients. METHODS: Adults age 60 years and older were randomly selected and screened for depression. Participants were randomly assigned to Usual Care or to an Intervention with a depression care-manager offering algorithm-based care for MDD. In all, 324 adults meeting criteria for MDD were included in these analyses. Remission and response was defined by a score on the Hamilton Rating Scale for Depression <10 and by a decrease from baseline of > or =50%, respectively. Medical comorbidity was ascertained through self-report. Cognitive impairment was defined by a score <24 on the Mini-Mental State Exam (MMSE). RESULTS: In Usual Care, rates of remission were faster in persons who reported atrial fibrillation (AF) than in persons who did not report AF and slower in persons who reported chronic pulmonary disease than in persons who did not report chronic pulmonary disease; rates of response were less stable in persons with MMSE <24 than in those with MMSE > or =24. In the Intervention condition, none of the specific chronic medical conditions were significantly associated with outcomes for MDD. CONCLUSIONS: Because disease-specific findings were observed in persons who received Usual Care but not in persons who received more intensive treatment in the Intervention condition, our results suggest that the association of medical comorbidity and treatment outcomes for MDD may be determined by the intensity of treatment for depression. 相似文献
8.
C Casanova C G Cote J M Marin J P de Torres A Aguirre-Jaime R Mendez L Dordelly B R Celli 《The European respiratory journal》2007,29(3):535-540
The 6-min walking distance (6MWD) test is used in clinical practice and research into patients with chronic obstructive pulmonary disease (COPD). However, little is known about natural long-term change in this parameter. The 6MWD was measured at baseline and then annually for 5 yrs in 294 patients with COPD and its annual rate of decline was determined. Forced expiratory volume in one second (FEV1) was also measured and the relationship between changes in both markers was explored. At baseline, the median 6MWD was 380 m (range 160-600 m). It declined by 19% (16 m.yr(-1)) over the 5 yrs compared with baseline in patients with American Thoracic Society/European Respiratory Society stage III COPD (FEV1 30-50% predicted) and by 26% (15 m.yr(-1)) in patients with stage IV COPD (FEV1 <30% pred). Over the 5-yr follow-up, the proportion of patients with a minimal clinically significant decline of 54 m increased with the severity of the disease. It was 24% in stage II, 45% in stage III, and 63% in stage IV disease. In contrast, the rate of decline of FEV1 was greater in patients with milder airflow obstruction and lesser in patients with lower absolute FEV1 values. In conclusion, the 6-min walking distance test provides increasingly useful information as the severity of chronic obstructive pulmonary disease increases. 相似文献
9.
Growth hormone signalling: sprouting links between pathways, human genetics and therapeutic options.
Iwona Pilecka Andrew Whatmore Rob Hooft van Huijsduijnen Benoit Destenaves Peter Clayton 《Trends in Endocrinology and Metabolism》2007,18(1):12-18
Our molecular understanding of growth hormone-induced signal transduction has improved significantly over the past decades. At the same time, human population genetics and the analysis of genetically engineered animals have led to the discovery of genes that control specific aspects of the overall growth process. Although, currently, growth disorders are still diagnosed and treated on empirical bases, it might soon be possible to stratify patients predominantly by genetic defect, with treatment based on our molecular understanding of the role of the affected gene in the disease. 相似文献
10.
Apathy: a neuropsychiatric syndrome. 总被引:5,自引:0,他引:5
R S Marin 《The Journal of neuropsychiatry and clinical neurosciences》1991,3(3):243-254
Traditionally, apathy has been viewed as a symptom indicating loss of interest or emotions. This paper evaluates evidence that neuropsychiatric disorders also produce a syndrome of apathy. Both the symptom and the syndrome of apathy are of conceptual interest because they signify loss of motivation. An apathy syndrome is defined as a syndrome of primary motivational loss, that is, loss of motivation not attributable to emotional distress, intellectual impairment, or diminished level of consciousness. Loss of motivation due to disturbance of intellect, emotion, or level of consciousness defines the symptom of apathy. Neuropsychiatric literature dealing with apathy is reviewed within the framework of three approaches to defining the concept of a syndrome. Clinical and investigative approaches for evaluating apathy when it occurs in association with other syndromes are described. 相似文献